Glutamate carboxypeptidase II: an amyloid peptide-degrading enzyme with physiological function in the brain

Structural Characterization of a Soluble Amyloid β-Peptide Oligomer

(2009) Liping Yu et al.   BIOCHEMISTRY

Oral administration of the NAALADase inhibitor GPI-5693 attenuates cocaine-induced reinstatement of drug-seeking behavior in rats

(2009) Xiao-Qing Peng et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

The Neuroactive Peptide N-Acetylaspartylglutamate Is Not an Agonist at the Metabotropic Glutamate Receptor Subtype 3 of Metabotropic Glutamate Receptor

(2009) M. Chopra et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Effects of N-acetylaspartylglutamate (NAAG) at group II mGluRs and NMDAR

(2009) Anne-Cécile Fricker et al.   NEUROPHARMACOLOGY

N-acetylaspartylglutamate (NAAG) inhibits intravenous cocaine self-administration and cocaine-enhanced brain-stimulation reward in rats

(2009) Zheng-Xiong Xi et al.   NEUROPHARMACOLOGY

Structural Basis of Interactions between Human Glutamate Carboxypeptidase II and Its Substrate Analogs

(2008) Cyril Barinka et al.   JOURNAL OF MOLECULAR BIOLOGY

Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory

(2008) Ganesh M Shankar et al.   NATURE MEDICINE

On the nucleation of amyloid β-protein monomer folding

(2005) Noel D. Lazo et al.   PROTEIN SCIENCE